Evidence map›Paper›PMID 37886207›Full record

ReviewHepatobiliary surgery and nutrition2023

The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions.

Tan-To Cheung, Yuk Tong Lee, Raymond Shing-Yan Tang, Wong Hoi She, Kai Chi Cheng, Chin Cheung Cheung, Keith Wan Hang Chiu, Kenneth Siu Ho Chok, Wing Sun Chow, Tak Wing Lai and 2 more

Open access · diamondAbstract readReview
In one paragraph

Review in Hepatobiliary surgery and nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Cystic neoplasms of pancreas.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Tan-To CheungDepartment of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Yuk Tong LeeGastroenterologist in private practice, Hong Kong, China.
Raymond Shing-Yan TangDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Wong Hoi SheDepartment of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Kai Chi ChengDepartment of Surgery, Kwong Wah Hospital, Hong Kong, China.
Chin Cheung CheungDepartment of Surgery, Tuen Mun Hospital, Hong Kong, China.
Keith Wan Hang ChiuDepartment of Radiology & Imaging, Queen Elizabeth Hospital, Hong Kong, China.
Kenneth Siu Ho ChokDepartment of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Wing Sun ChowDepartment of Medicine, The University of Hong Kong, Hong Kong, China.
Tak Wing LaiDepartment of Surgery, Princess Margaret Hospital, Hong Kong, China.
Wai-Kay SetoDepartment of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China.
Thomas YauDepartment of Medicine, The University of Hong Kong, Hong Kong, China.
University of Hong Kong · HKChinese University of Hong Kong · HKKwong Wah Hospital · CNQueen Elizabeth Hospital · CNQueen Mary Hospital · CNTuen Mun Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The finding of pancreatic cystic lesions (PCL) on incidental imaging is becoming increasingly common. International studies report a prevalence of 2.2-44.7% depending on the population, imaging modality and indication for imaging, and the prevalence increases with age. Patients with PCL are at risk of developing pancreatic cancer, a disease with a poor prognosis. This publication summarizes recommendations for the diagnosis and management of PCL and post-operative pancreatic exocrine insufficiency (PEI) from a group of local specialists. Methods: Clinical evidence was consolidated from narrative reviews and consensus statements formulated during two online meetings in March 2022. The expert panel included gastroenterologists, hepatobiliary surgeons, oncologists, radiologists, and endocrinologists. Results: Patients with PCL require careful investigation and follow-up due to the risk of malignant transformation of these lesions. They should undergo clinical investigation and pancreas-specific imaging to classify lesions and understand the risk profile of the patient. Where indicated, patients should undergo pancreatectomy to excise PCL. Following pancreatectomy, patients are at risk of PEI, leading to gastrointestinal dysfunction and malnutrition. Therefore, such patients should be monitored for symptoms of PEI, and promptly treated with pancreatic enzyme replacement therapy (PERT). Patients with poor response to PERT may require increases in dose, addition of a proton pump inhibitor, and/or further investigation, including tests for pancreatic function. Patients are also at risk of new-onset diabetes mellitus after pancreatectomy; they should be screened and treated with insulin if indicated. Conclusions: These statements are an accurate summary of our approach to the diagnosis and management of patients with PCL and will be of assistance to clinicians treating these patients in a similar clinical landscape.

Indexed as

Pancreatic cystic lesionspancreatic endocrine insufficiencypancreatic enzyme replacement therapy

Identifiers

PMID37886207
PMCPMC10598309
OpenAlexW4386820004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.